Glenmede Trust’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.63M Buy
151,155
+44,292
+41% +$1.82M 0.03% 429
2025
Q4
$5M Buy
+106,863
New +$4.62M 0.02% 440
2025
Q1
$3.35M Buy
66,435
+15,039
+29% +$746K 0.02% 474
2024
Q4
$2.21M Buy
51,396
+8,240
+19% +$348K 0.01% 531
2024
Q3
$1.69M Buy
43,156
+926
+2% +$33.5K 0.01% 604
2024
Q2
$1.36M Sell
42,230
-35,916
-46% -$1.16M 0.01% 628
2024
Q1
$2.57M Sell
78,146
-270
-0.3% -$9.38K 0.01% 527
2023
Q4
$2.72M Sell
78,416
-3,341
-4% -$115K 0.01% 495
2023
Q3
$2.96M Sell
81,757
-321
-0.4% -$11.9K 0.02% 457
2023
Q2
$3.79M Hold
82,078
0.02% 432
2023
Q1
$3.79M Sell
82,078
-2,050
-2% -$95.7K 0.02% 432
2022
Q4
$3.9M Sell
84,128
-1,797
-2% -$81.7K 0.02% 437
2022
Q3
$3.76M Sell
85,925
-8,489
-9% -$390K 0.02% 421
2022
Q2
$4M Sell
94,414
-14,049
-13% -$596K 0.02% 424
2022
Q1
$4.72M Buy
108,463
+1,518
+1% +$70.4K 0.02% 420
2021
Q4
$5.67M Buy
106,945
+1,362
+1% +$68.5K 0.03% 423
2021
Q3
$5.01M Buy
105,583
+10,748
+11% +$534K 0.03% 415
2021
Q2
$4.31M Sell
94,835
-25,699
-21% -$1.16M 0.02% 421
2021
Q1
$5.16M Sell
120,534
-4,904
-4% -$204K 0.03% 393
2020
Q4
$5.19M Sell
125,438
-40,435
-24% -$1.6M 0.03% 398
2020
Q3
$6.46M Sell
165,873
-42,557
-20% -$1.68M 0.04% 355
2020
Q2
$7.61M Buy
208,430
+66,229
+47% +$2.24M 0.05% 339
2020
Q1
$6M Hold
142,201
0.03% 423
2019
Q4
$6M Buy
142,201
+15,236
+12% +$609K 0.03% 423
2019
Q3
$4.92K Buy
126,965
+81,605
+180% +$3.23M 0.02% 445
2019
Q2
$1.73K Sell
45,360
-5,315
-10% -$193K 0.01% 654
2019
Q1
$1.78K Sell
50,675
-52
-0.1% -$1.64K 0.01% 649
2018
Q4
$1.37K Sell
50,727
-589
-1% -$16.8K 0.01% 673
2018
Q3
$1.57M Buy
51,316
+521
+1% +$15.8K 0.01% 680
2018
Q2
$1.47M Sell
50,795
-61,601
-55% -$1.91M 0.01% 646
2018
Q1
$3.57M Hold
112,396
0.01% 549
2017
Q4
$3.57M Buy
112,396
+198
+0.2% +$6.13K 0.01% 549
2017
Q3
$3.23M Sell
112,198
-2,229
-2% -$63.5K 0.01% 560
2017
Q2
$2.83M Hold
114,427
0.01% 585
2017
Q1
$2.83M Buy
114,427
+291
+0.3% +$7.09K 0.01% 585
2016
Q4
$2.78M Buy
114,136
+2,675
+2% +$63.7K 0.02% 569
2016
Q3
$2.67M Hold
111,461
0.02% 574
2016
Q2
$2.99M Buy
111,461
+349
+0.3% +$9.6K 0.02% 539
2016
Q1
$3.02M Sell
111,112
-67,071
-38% -$1.7M 0.02% 527
2015
Q4
$4.45M Buy
178,183
+57,485
+48% +$1.42M 0.03% 453
2015
Q3
$2.85M Buy
120,698
+8,170
+7% +$183K 0.02% 516
2015
Q2
$2.4M Buy
112,528
+1,642
+1% +$36.8K 0.02% 539
2015
Q1
$2.58M Buy
110,886
+7,460
+7% +$161K 0.02% 539
2014
Q4
$1.96M Sell
103,426
-59
-0.1% -$1.04K 0.02% 578
2014
Q3
$1.69M Buy
103,485
+32,720
+46% +$573K 0.01% 582
2014
Q2
$1.24M Buy
+70,765
New +$1.21M 0.01% 642
2013
Q4
Sell
-432
Closed -$8K 2296
2013
Q3
$8K Sell
432
-256
-37% -$5.1K ﹤0.01% 1968
2013
Q2
$13K Buy
+688
New +$13.1K ﹤0.01% 1821

Other funds holding G

Glenmede Trust's G Position: Q1 2026 in Review

Glenmede Trust increased its Genpact (G) stake by 41% in Q1 2026, buying an estimated $1.82M and bringing the position to 151,155 shares worth $5.63M. The position accounts for 0.03% of the portfolio, ranked #429.

Glenmede Trust first reported a position in G in Q2 2013 and has held it in 48 quarters since. The position peaked at $7.61M in Q2 2020. 515 funds tracked by Wall St. Rank hold G as of Q1 2026.

  • Glenmede Trust held 151,155 shares of Genpact worth $5.63M as of Q1 2026.
  • Glenmede Trust bought 44,292 Genpact shares in Q1 2026, an estimated $1.82M.
  • Genpact made up 0.03% of Glenmede Trust's portfolio in Q1 2026, its #429 holding.
  • Glenmede Trust first reported a position in Genpact in Q2 2013 and has held it in 48 quarters since.
  • Glenmede Trust's Genpact position peaked at $7.61M in Q2 2020.
  • 515 funds tracked by Wall St. Rank held Genpact as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.